What is a fiduciary (fiducial) marker in Magnetic Resonance Imaging (MRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Fiducial Marker in MRI?

A fiducial marker in MRI is a reference object containing contrast material (such as copper sulfate solution or gadolinium) that is placed on or near the patient's body to serve as a fixed spatial reference point for image registration, alignment between different imaging modalities (MRI-CT-ultrasound fusion), stereotactic procedures, and accurate repositioning across serial imaging sessions.

Primary Clinical Applications

Image Registration and Fusion

  • Fiducial markers enable automated fusion of MR images with ultrasound or CT images by providing identifiable reference points that are visible across multiple imaging modalities 1
  • The markers facilitate accurate spatial alignment when transferring MRI-delineated target volumes to planning CT scans for radiotherapy treatment planning 2
  • External fiducial marker systems using contrast-filled wells (typically 1 g/L copper sulfate solution) can achieve automatic image fusion accuracy within 5 mm for breath-hold abdominal scanning 1

Stereotactic and Radiotherapy Guidance

  • Internal gold fiducial markers are commonly implanted in tissues (such as prostate or rectal tumors) to define internal structures visible on both planning MRI and treatment positioning images 2, 3
  • Cylindrical gold markers demonstrate position deviations of less than 1 mm on MRI despite susceptibility artifacts, making them suitable as internal fiducial markers 2
  • For rectal cancer radiotherapy, Visicoil 0.75 and Gold Anchor fiducials are the most consistently identifiable on MRI when used with registered CT and T1 3D GRE sequences 3

Serial Imaging Alignment

  • External fiducial marker systems (such as spectacle-frame mounted markers with individualized ear canal imprints) enable repositioning accuracy of ±1.6 mm in left-right and anterior-posterior directions and ±1.9 mm in cranio-caudal direction across repeated MRI examinations 4
  • These systems are particularly valuable when intrinsic anatomical landmarks are insufficient for accurate image alignment 4

Technical Characteristics

Marker Composition and Design

  • External markers typically consist of small cylindrical wells (approximately 6.4 mL volume) filled with paramagnetic contrast solutions such as copper sulfate or gadolinium 1
  • Tuned fiducial markers contain short T1 solutions surrounded by single- or quadrature-tuned RF windings that enhance signal without significantly perturbing tissue magnetization 5
  • Internal markers are usually gold-based due to biocompatibility and visibility across multiple imaging modalities (MRI, CT, X-ray) 2, 3

MRI Visibility Considerations

  • Gold fiducial visibility on MRI depends on marker shape, orientation relative to the main magnetic field, and susceptibility effects that create signal voids 2, 3
  • T1 3D gradient echo (GRE) sequences provide superior visualization of gold fiducials compared to T2-weighted sequences 3
  • Fiducial identification is significantly improved when registered CT images are available alongside MRI for correlation 3

Critical Pitfalls and Limitations

Susceptibility Artifacts

  • Metal fiducial markers create magnetic field distortions that can obscure adjacent anatomy on MRI 2
  • The artifact size and shape vary with marker geometry, orientation, and MRI sequence parameters 2
  • Cylindrical gold markers oriented parallel to the main magnetic field minimize susceptibility artifacts compared to other shapes 2

Detection Challenges

  • Without correlative CT imaging, fiducial identification on MRI alone is poor, with observers frequently unable to consistently locate markers 3
  • Marker migration between imaging sessions can occur, particularly with internal markers in mobile tissues 3
  • In rectal cancer patients, only 7 out of 9 Visicoil 0.75 fiducials were consistently identified on the first MRI, decreasing to 2 out of 7 on subsequent imaging 3

Practical Implementation

For Stereotactic Procedures

  • Fixation devices and stereotactic frames with integrated fiducial markers provide the highest precision for neurosurgical applications 6
  • When stereotactic frames are not feasible, computer programs for volumetric display and reconstruction combined with anatomical landmark orientation serve as alternatives 6

For Serial Disease Monitoring

  • In multiple sclerosis monitoring protocols, accurate repositioning around well-visualized anatomical landmarks is recommended rather than relying on external fiducial systems 6
  • Geometrical markers should be included on hard copy images for quality control and spatial reference 6

For Radiotherapy Planning

  • A registered CT scan should always accompany MRI when using fiducial markers for radiotherapy target definition to ensure accurate fiducial-to-target spatial relationships 3
  • Auto-segmentation algorithms can achieve 100% detection rates for properly designed external fiducial devices across clinical abdominal MR sequences 1

References

Research

Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.

International journal of radiation oncology, biology, physics, 2012

Research

MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019

Research

A new set of fiducial markers for MRI, CT and SPET alignment.

Nuclear medicine communications, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.